Architecting Compliant Individual Case Safety Report (ICSR) Pipelines for FDA and EMA

Core clinical engineering and protocols for ICH E2B(R3) Compliance.

The Regulatory Burden of Post-Market Safety Reporting

Pharmaceutical manufacturers are legally obligated to review all reports of adverse events related to their products. For serious, unexpected adverse reactions, companies must transmit an E2B(R3) XML report to the FDA and EMA within 15 calendar days of receipt.

Automating the ICSR Lifecycle

PharmacoPlatform automates the entire case intake workflow: optical character recognition parses paper MedWatch forms, clinical NLP extracts patient demographics and drug dosages, and rule engines validate that all mandatory ICH E2B(R3) data elements are present, eliminating manual data entry bottlenecks.

Исследовать портфель доменов Health